SmallCap
CompaniesMapStatistics

(주)아미노로직스

Venture Certified
Data Quality: 95/10

Basic Information


Unlisted

Company Name(주)아미노로직스
English NameAMINOLOGICS CO.,LTD.
Business Reg. No.1298123337
CEO오장석,오성석
Address서울특별시 강남구 역삼로 151 삼오빌딩3층 301호
Industry의약품 도매업
Industry Code46441
EstablishedContact
Phone02-761-4570
Websitewww.aminologics.co.kr
Regular Employees40persons
Corp. Reg. No.1311110030369

Investment Metrics


Market Cap
-
Op. Margin
-12.82%
ROE
-2.14%
Debt Ratio
9.84%

Certification Status


Venture Certified

Cert. History
연구개발기업1999-05-07 ~ 2000-12-311999162521-06531999-05-07
연구개발기업2001-08-10 ~ 2003-08-090116290212034721999-05-07
연구개발기업2003-08-10 ~ 2005-08-090316261313005801999-05-07
연구개발기업2005-08-10 ~ 2007-08-090516261214009961999-05-07
연구개발유형2007-08-10 ~ 2009-08-09200701025701999-05-07
연구개발유형2009-08-10 ~ 2011-08-09200901065431999-05-07
연구개발유형2011-08-10 ~ 2013-08-09201101047061999-05-07
연구개발유형2013-08-10 ~ 2015-08-09201301075011999-05-07
연구개발유형2015-08-10 ~ 2017-08-09201501081261999-05-07
연구개발유형2017-11-03 ~ 2019-11-02201701127651999-05-07
연구개발유형2019-11-03 ~ 2021-11-02201901126651999-05-07
연구개발유형2021-11-03 ~ 2024-11-02202111040200041999-05-07
연구개발유형2024-11-03 ~ 2027-11-02202411200200141999-05-07

Financial Statements


3-Year Financial Data

Revenue CAGR -21.6%

Item202420232022
Revenue

168B

209B

273B

Operating Profit

-22B

15B

70B

Net Profit

-11B

23B

-63B

Total Assets

568B

577B

556B

Total Liabilities

51B

33B

42B

Total Equity

517B

544B

514B

Risk Indicators


2 Risk Indicators

Comparison Metrics


vs. 3-Year Avg.
Based on 2024
Revenue
168B

30.4%

vs. 3-Year Avg.: 241B
Operating Profit
-22B

150.7%

vs. 3-Year Avg.: 42B
Op. Margin
-12.8%

178.4%

vs. 3-Year Avg.: 16.4%
Debt Ratio
9.8%

39.7%

vs. 3-Year Avg.: 7.0%
ROE
-2.1%

46.6%

vs. 3-Year Avg.: -4.0%

Officers / Major Shareholders


Only CEO info available (unlisted company)
NamePositionRole
오장석,오성석대표이사대표

Employment Status


NPS Subscribers

40persons

CEO오장석,오성석
Est. Avg. Annual Salary

5,48510K

(45710K/mo)
Based on NPS rate 9.5%
Hired (12 mo)

+1persons

Left (12 mo)

-0persons

Net Change (12 mo)

+1persons

NPS Join Date

1997-10-28

Monthly Employee Trend
Hired
Left

Patent Status

Updated: 2026-02-25

47 Patents
1 Registered
2 in 3 Years
H04 전기 통신 기술 (57)
C07 유기화학 (51)
G11 정보 저장 (7)
B01 물리적/화학적 공정 (4)
C12 생화학/미생물학 (4)
Patent TitleApplicantApplication No.Filing DateStatus
신규 중간체 및 이를 이용하는 H-AEEA-AEEA-OH의 제조방법주식회사 아미노로직스10202500974902025-07-18공개
모노-터트-부틸 에스터화된 포화 탄화수소의 제조방법 및 이의 순환적 제조방법주식회사 아미노로직스10202300603472023-05-10공개
광학 활성을 가진 2-옥틸글리신 에스터를 제조하는 방법주식회사 아미노로직스10201701703152017-12-12소멸
DL-4,4'-바이페닐알라닌 알킬에스터로부터 D-4,4'-바이페닐알라닌 알킬에스터 또는 L-4,4'-바이페닐알라닌 알킬에스터를 제조하는 방법주식회사 아미노로직스10201600474622016-04-19거절
아미노벤즈알데히드 유도체 및 이를 포함하는 아미노산 키랄 추출제주식회사 아미노로직스|이화여자대학교 산학협력단10201501773132015-12-11포기

Procurement Record

Updated: 2026-02-25

No Data Contact

No procurement record or data not yet available

Support Programs


No Data Contact

No matching support programs for this industry

Tax / Business Status

Updated: 2026-02-25

Business Status: active
Tax Type부가가치세 일반과세자

SME Status


Venture
Status

Cert. flags confirmed (details update after further collection)

Other Public Data


2 Additional Data Sources

{
  "address": "서울특별시 강남구 역삼로",
  "brno": "129812****",
  "cappedWarning": false,
  "companyName": "(주)아미노로직스",
  "estimatedAvgAnnualSalary": 54851868,
  "estimatedAvgMonthlySalary": 4570989,
  "fetchedAt": "2026-03-05T18:52:03.985Z",
  "industryCode": "321000",
  "industryName": "기타 반도체 소자 제조업",
  "joinDate": "19971028",
  "last12MonthsHired": 1,
  "last12MonthsLeft": 0,
  "last12MonthsNetChange": 1,
  "leaveDate": null,
  "monthlyPensionAmount": 17369760,
  "monthlyTrend": [
    {
      "lostSubscribers": 0,
      "newSubscribers": 1,
      "yearMonth": null
    }
  ],
  "npsRateUsed": 0.095,
  "npsUpperCap": 6370000,
  "seq": "6407106",
  "status": "1",
  "styleCode": "1",
  "subscriberCount": 40,
  "turnoverMonths": 1
}

{
  "address": "서울특별시 강남구",
  "ceo_name": "오장석, 오성석",
  "certificate": [
    {
      "cert_number": "1999162521-0653",
      "changes": "",
      "disclosure_date": "1999-05-07",
      "first_cert_date": "1999-05-07",
      "no": "1",
      "type": "연구개발기업",
      "valid_period": "1999-05-07 ~ 2000-12-31"
    },
    {
      "cert_number": "011629021203472",
      "changes": "",
      "disclosure_date": "2001-08-10",
      "first_cert_date": "1999-05-07",
      "no": "2",
      "type": "연구개발기업",
      "valid_period": "2001-08-10 ~ 2003-08-09"
    },
    {
      "cert_number": "031626131300580",
      "changes": "",
      "disclosure_date": "2003-08-10",
      "first_cert_date": "1999-05-07",
      "no": "3",
      "type": "연구개발기업",
      "valid_period": "2003-08-10 ~ 2005-08-09"
    },
    {
      "cert_number": "051626121400996",
      "changes": "",
      "disclosure_date": "2005-08-10",
      "first_cert_date": "1999-05-07",
      "no": "4",
      "type": "연구개발기업",
      "valid_period": "2005-08-10 ~ 2007-08-09"
    },
    {
      "cert_number": "20070102570",
      "changes": "",
      "disclosure_date": "2007-08-09",
      "first_cert_date": "1999-05-07",
      "no": "5",
      "type": "연구개발유형",
      "valid_period": "2007-08-10 ~ 2009-08-09"
    },
    {
      "cert_number": "20090106543",
      "changes": "",
      "disclosure_date": "2009-07-03",
      "first_cert_date": "1999-05-07",
      "no": "6",
      "type": "연구개발유형",
      "valid_period": "2009-08-10 ~ 2011-08-09"
    },
    {
      "cert_number": "20110104706",
      "changes": "",
      "disclosure_date": "2011-07-26",
      "first_cert_date": "1999-05-07",
      "no": "7",
      "type": "연구개발유형",
      "valid_period": "2011-08-10 ~ 2013-08-09"
    },
    {
      "cert_number": "20130107501",
      "changes": "",
      "disclosure_date": "2013-07-22",
      "first_cert_date": "1999-05-07",
      "no": "8",
      "type": "연구개발유형",
      "valid_period": "2013-08-10 ~ 2015-08-09"
    },
    {
      "cert_number": "20150108126",
      "changes": "",
      "disclosure_date": "2015-08-05",
      "first_cert_date": "1999-05-07",
      "no": "9",
      "type": "연구개발유형",
      "valid_period": "2015-08-10 ~ 2017-08-09"
    },
    {
      "cert_number": "20170112765",
      "changes": "",
      "disclosure_date": "2017-11-03",
      "first_cert_date": "1999-05-07",
      "no": "10",
      "type": "연구개발유형",
      "valid_period": "2017-11-03 ~ 2019-11-02"
    },
    {
      "cert_number": "20190112665",
      "changes": "",
      "disclosure_date": "2019-10-31",
      "first_cert_date": "1999-05-07",
      "no": "11",
      "type": "연구개발유형",
      "valid_period": "2019-11-03 ~ 2021-11-02"
    },
    {
      "cert_number": "20211104020004",
      "changes": "",
      "disclosure_date": "2021-11-04",
      "first_cert_date": "1999-05-07",
      "no": "12",
      "type": "연구개발유형",
      "valid_period": "2021-11-03 ~ 2024-11-02"
    },
    {
      "cert_number": "20241120020014",
      "changes": "",
      "disclosure_date": "2024-11-20",
      "first_cert_date": "1999-05-07",
      "no": "13",
      "type": "연구개발유형",
      "valid_period": "2024-11-03 ~ 2027-11-02"
    }
  ],
  "company_name": "㈜아미노로직스",
  "financials": {
    "2022": {
      "capital_stock": 8782684000,
      "cost_of_sales": 14528867000,
      "current_assets": 43567648000,
      "current_liabilities": 3423997000,
      "gross_profit": 12808061000,
      "net_income": -6280725000,
      "net_income_bs": -7281575000,
      "non_current_assets": 12013104000,
      "non_current_liabilities": 749491000,
      "non_operating_expenses": 15272206000,
      "non_operating_income": 1956836000,
      "operating_profit": 7034645000,
      "revenue": 27336928000,
      "sga_expenses": 5773416000,
      "total_assets": 55580752000,
      "total_equity": 51407264000,
      "total_liabilities": 4173488000
    },
    "2023": {
      "capital_stock": 8782684000,
      "cost_of_sales": 13110991000,
      "current_assets": 45247398000,
      "current_liabilities": 2662843000,
      "gross_profit": 7775632000,
      "net_income": 2290868000,
      "net_income_bs": 2436181000,
      "non_current_assets": 12419232000,
      "non_current_liabilities": 589535000,
      "non_operating_expenses": 652791000,
      "non_operating_income": 1481643000,
      "operating_profit": 1462016000,
      "revenue": 20886623000,
      "sga_expenses": 6313616000,
      "total_assets": 57666630000,
      "total_equity": 54414252000,
      "total_liabilities": 3252378000
    },
    "2024": {
      "capital_stock": 8782684000,
      "cost_of_sales": 13371553000,
      "current_assets": 46515682000,
      "current_liabilities": 4336609000,
      "gross_profit": 3418720000,
      "net_income": -1104432000,
      "net_income_bs": -1619873000,
      "non_current_assets": 10271988000,
      "non_current_liabilities": 734769000,
      "non_operating_expenses": 1175802000,
      "non_operating_income": 2224418000,
      "operating_profit": -2153048000,
      "revenue": 16790273000,
      "sga_expenses": 5571768000,
      "total_assets": 56787670000,
      "total_equity": 51699177000,
      "total_liabilities": 5088493000
    }
  },
  "industry": "의약품 도매업",
  "investment": [],
  "phone": "02-761-****",
  "source": "pg_migration"
}

Data Sources


Data Quality: 95/10 | Primary Source: Venture System | Section Coverage: 8/8

Data Sources by Section
SectionSource:Status
Basic InfoDART
Collected
Financial StatementsVenture System
Collected
Investment MetricsVenture System
Collected
OfficersDART
Collected
EmploymentPublic Data
Collected
CertificationsPublic Data
Collected
PatentsKIPRIS
Collected
ProcurementG2B Procurement
Collected
Collected API Sources
APICollectedStatus
nps2026-03-05
Collected
Venture System Detail2026-03-05
Collected
DART Financial2026-02-26
Collected
G2B Procurement2026-02-25
Collected
Employment Insurance2026-02-25
Collected
KIPRIS Patents2026-02-25
Collected
HomeTax Business2026-02-25
Collected
Cert. Info2026-02-25
Collected